Free Cash Flow Build Up

SELLAS Life Sciences Group, Inc. (SLS)

$2.2

-0.03 (-1.35%)
Year
A/P
Revenue
EBITDA
EBIT
Tax Rate
EBIAT
Depreciation
Accounts Receivable
Inventories
Accounts Payable
Capital Expenditure
UFCF
WACC
PV UFCF
SUM PV UFCF